Janet Cohen Sherman, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cerebellar Diseases | 7 | 2021 | 226 | 1.540 |
Why?
|
| Cognition Disorders | 8 | 2021 | 4043 | 0.690 |
Why?
|
| Cognition | 13 | 2022 | 6770 | 0.340 |
Why?
|
| Neuropsychological Tests | 15 | 2022 | 6993 | 0.310 |
Why?
|
| Telemedicine | 2 | 2021 | 2872 | 0.300 |
Why?
|
| Glioma | 3 | 2019 | 3401 | 0.290 |
Why?
|
| Neuropsychology | 2 | 2021 | 110 | 0.230 |
Why?
|
| Memory, Short-Term | 2 | 2021 | 975 | 0.230 |
Why?
|
| Obesity, Abdominal | 2 | 2016 | 361 | 0.220 |
Why?
|
| Alzheimer Disease | 3 | 2021 | 8037 | 0.200 |
Why?
|
| Cerebellum | 1 | 2007 | 1488 | 0.170 |
Why?
|
| Brain Neoplasms | 3 | 2019 | 8863 | 0.170 |
Why?
|
| Executive Function | 5 | 2018 | 1364 | 0.160 |
Why?
|
| Ataxia Telangiectasia | 1 | 2019 | 112 | 0.160 |
Why?
|
| Neurosecretory Systems | 1 | 2019 | 231 | 0.150 |
Why?
|
| Semantics | 2 | 1993 | 584 | 0.150 |
Why?
|
| Affect | 4 | 2019 | 1476 | 0.150 |
Why?
|
| Mental Recall | 2 | 2018 | 1205 | 0.150 |
Why?
|
| Language | 2 | 2021 | 1471 | 0.140 |
Why?
|
| Frontotemporal Lobar Degeneration | 1 | 2017 | 99 | 0.140 |
Why?
|
| Aphasia, Primary Progressive | 1 | 2017 | 73 | 0.140 |
Why?
|
| Visual Perception | 3 | 2018 | 1420 | 0.130 |
Why?
|
| Human Growth Hormone | 2 | 2016 | 683 | 0.120 |
Why?
|
| Corpus Callosum | 1 | 2019 | 737 | 0.120 |
Why?
|
| Longevity | 1 | 2021 | 1070 | 0.110 |
Why?
|
| Reference Values | 1 | 2021 | 4982 | 0.110 |
Why?
|
| Atrophy | 1 | 2018 | 1583 | 0.110 |
Why?
|
| Neurodegenerative Diseases | 1 | 2022 | 1061 | 0.110 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 2016 | 548 | 0.110 |
Why?
|
| Attention | 4 | 2016 | 2400 | 0.110 |
Why?
|
| Testosterone | 3 | 2016 | 2420 | 0.110 |
Why?
|
| Social Perception | 1 | 2016 | 425 | 0.110 |
Why?
|
| Memory | 3 | 2016 | 2174 | 0.110 |
Why?
|
| Memory Disorders | 2 | 2018 | 1184 | 0.110 |
Why?
|
| Concept Formation | 1 | 1993 | 158 | 0.100 |
Why?
|
| Radiation Injuries | 1 | 2019 | 1180 | 0.100 |
Why?
|
| Language Development | 1 | 1993 | 187 | 0.100 |
Why?
|
| Temporal Lobe | 2 | 2017 | 1670 | 0.100 |
Why?
|
| Axons | 1 | 2019 | 1684 | 0.090 |
Why?
|
| Mood Disorders | 1 | 1997 | 1106 | 0.090 |
Why?
|
| Neurologic Examination | 3 | 2018 | 930 | 0.090 |
Why?
|
| Neuronal Ceroid-Lipofuscinoses | 1 | 2011 | 142 | 0.090 |
Why?
|
| Aphasia, Broca | 1 | 1989 | 50 | 0.090 |
Why?
|
| Limbic Encephalitis | 1 | 2008 | 34 | 0.080 |
Why?
|
| Adiposity | 2 | 2016 | 1807 | 0.080 |
Why?
|
| Dementia | 1 | 2022 | 2518 | 0.080 |
Why?
|
| Aphasia | 1 | 1989 | 179 | 0.080 |
Why?
|
| Syndrome | 3 | 2019 | 3251 | 0.070 |
Why?
|
| Carcinoid Tumor | 1 | 2008 | 235 | 0.070 |
Why?
|
| Mental Disorders | 1 | 2007 | 6600 | 0.070 |
Why?
|
| Humans | 30 | 2022 | 744343 | 0.070 |
Why?
|
| Learning | 1 | 2016 | 1713 | 0.070 |
Why?
|
| Verbal Learning | 2 | 2018 | 467 | 0.070 |
Why?
|
| Mediastinal Neoplasms | 1 | 2008 | 423 | 0.070 |
Why?
|
| Speech Perception | 1 | 1989 | 489 | 0.060 |
Why?
|
| Pandemics | 2 | 2021 | 8388 | 0.060 |
Why?
|
| Multiple Sclerosis | 1 | 2019 | 3079 | 0.060 |
Why?
|
| Aged | 11 | 2022 | 163280 | 0.060 |
Why?
|
| Hypopituitarism | 1 | 2006 | 254 | 0.060 |
Why?
|
| Middle Aged | 17 | 2019 | 213383 | 0.060 |
Why?
|
| Adult | 17 | 2019 | 214055 | 0.060 |
Why?
|
| Young Adult | 7 | 2019 | 56430 | 0.060 |
Why?
|
| Reading | 1 | 1986 | 558 | 0.050 |
Why?
|
| Female | 21 | 2019 | 380194 | 0.050 |
Why?
|
| Male | 18 | 2019 | 350118 | 0.050 |
Why?
|
| Hormone Replacement Therapy | 1 | 2006 | 745 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 15540 | 0.040 |
Why?
|
| Body Composition | 3 | 2016 | 2401 | 0.040 |
Why?
|
| Androgens | 1 | 2006 | 1281 | 0.040 |
Why?
|
| Child | 3 | 2021 | 77709 | 0.040 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2018 | 6038 | 0.040 |
Why?
|
| Quality of Life | 4 | 2019 | 12804 | 0.040 |
Why?
|
| Multiple Sclerosis, Chronic Progressive | 1 | 2019 | 236 | 0.040 |
Why?
|
| Emotional Intelligence | 1 | 2016 | 136 | 0.030 |
Why?
|
| Cerebellar Ataxia | 1 | 2016 | 145 | 0.030 |
Why?
|
| Brain | 4 | 2017 | 26385 | 0.030 |
Why?
|
| Fatal Outcome | 2 | 2011 | 1850 | 0.030 |
Why?
|
| ROC Curve | 1 | 2022 | 3527 | 0.030 |
Why?
|
| Stroke | 1 | 2016 | 9981 | 0.030 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2019 | 518 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2022 | 19905 | 0.030 |
Why?
|
| Autopsy | 1 | 2017 | 1020 | 0.030 |
Why?
|
| Brain Chemistry | 1 | 2017 | 981 | 0.030 |
Why?
|
| Parietal Lobe | 1 | 2018 | 838 | 0.030 |
Why?
|
| Cerebellar Neoplasms | 1 | 1998 | 587 | 0.030 |
Why?
|
| Cerebral Infarction | 1 | 1998 | 1011 | 0.030 |
Why?
|
| Psycholinguistics | 1 | 1993 | 78 | 0.030 |
Why?
|
| Child Language | 1 | 1993 | 64 | 0.030 |
Why?
|
| Body Weight | 1 | 2003 | 4669 | 0.030 |
Why?
|
| Empathy | 1 | 2016 | 474 | 0.030 |
Why?
|
| Weight Loss | 1 | 2003 | 2622 | 0.030 |
Why?
|
| Disability Evaluation | 1 | 2019 | 1827 | 0.020 |
Why?
|
| Child, Preschool | 3 | 2021 | 41006 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2021 | 5078 | 0.020 |
Why?
|
| Cerebrovascular Disorders | 1 | 1998 | 1504 | 0.020 |
Why?
|
| Insulin Resistance | 2 | 2016 | 3864 | 0.020 |
Why?
|
| Obesity | 1 | 2013 | 12745 | 0.020 |
Why?
|
| Epilepsies, Myoclonic | 1 | 2011 | 80 | 0.020 |
Why?
|
| Double-Blind Method | 3 | 2016 | 12026 | 0.020 |
Why?
|
| Anomia | 1 | 1989 | 14 | 0.020 |
Why?
|
| Hydrocephalus | 1 | 1996 | 748 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2013 | 2015 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2019 | 2703 | 0.020 |
Why?
|
| Adolescent | 5 | 2019 | 85781 | 0.020 |
Why?
|
| Prospective Studies | 3 | 2019 | 53288 | 0.020 |
Why?
|
| Genes, Dominant | 1 | 2011 | 880 | 0.020 |
Why?
|
| Cohort Studies | 3 | 2019 | 40561 | 0.020 |
Why?
|
| Mediastinum | 1 | 2008 | 267 | 0.020 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2019 | 2737 | 0.020 |
Why?
|
| Adiponectin | 1 | 2013 | 1100 | 0.020 |
Why?
|
| Body Mass Index | 2 | 2016 | 12720 | 0.020 |
Why?
|
| Confusion | 1 | 2008 | 275 | 0.020 |
Why?
|
| Cross-Sectional Studies | 3 | 2016 | 25043 | 0.020 |
Why?
|
| Motor Activity | 1 | 2016 | 2714 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2016 | 6459 | 0.020 |
Why?
|
| Estrogens | 1 | 2013 | 1566 | 0.020 |
Why?
|
| Form Perception | 1 | 1986 | 182 | 0.020 |
Why?
|
| Encephalitis | 1 | 2008 | 423 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 2011 | 12959 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2015 | 6895 | 0.010 |
Why?
|
| Adrenal Insufficiency | 1 | 2006 | 184 | 0.010 |
Why?
|
| Pedigree | 1 | 2011 | 4644 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 57776 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2016 | 8324 | 0.010 |
Why?
|
| Intelligence Tests | 1 | 2003 | 505 | 0.010 |
Why?
|
| Disease Progression | 1 | 2019 | 13284 | 0.010 |
Why?
|
| Brain Ischemia | 1 | 2016 | 3265 | 0.010 |
Why?
|
| Homeostasis | 1 | 2013 | 3340 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2019 | 8949 | 0.010 |
Why?
|
| Hormones | 1 | 2006 | 889 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2013 | 3279 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2017 | 6234 | 0.010 |
Why?
|
| Epilepsy | 1 | 1996 | 3310 | 0.010 |
Why?
|
| Time Factors | 3 | 2016 | 40075 | 0.010 |
Why?
|
| Arousal | 1 | 2006 | 1165 | 0.010 |
Why?
|
| Reaction Time | 1 | 1986 | 2097 | 0.010 |
Why?
|
| Radiography | 1 | 2011 | 7023 | 0.010 |
Why?
|
| Hypogonadism | 1 | 2006 | 799 | 0.010 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2003 | 712 | 0.010 |
Why?
|
| Vitamin D | 1 | 2013 | 3223 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2017 | 9648 | 0.010 |
Why?
|
| Insulin | 1 | 2013 | 6580 | 0.010 |
Why?
|
| Seizures | 1 | 2011 | 2859 | 0.010 |
Why?
|
| Pituitary Diseases | 1 | 1998 | 141 | 0.010 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2003 | 2559 | 0.010 |
Why?
|
| HIV Infections | 1 | 2003 | 16718 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2013 | 13989 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2008 | 35421 | 0.010 |
Why?
|
| Sexual Behavior | 1 | 2006 | 2057 | 0.010 |
Why?
|
| Hemosiderosis | 1 | 1996 | 71 | 0.010 |
Why?
|
| Electroencephalography | 1 | 2011 | 6150 | 0.010 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 1996 | 194 | 0.010 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2003 | 1873 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2011 | 5708 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 1996 | 15295 | 0.010 |
Why?
|
| Placebos | 1 | 1998 | 1676 | 0.010 |
Why?
|
| Bone Density | 1 | 2006 | 3468 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2016 | 63114 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2008 | 20129 | 0.010 |
Why?
|
| Lung | 1 | 2008 | 9856 | 0.010 |
Why?
|
| Sex Factors | 1 | 2003 | 10397 | 0.010 |
Why?
|
| Functional Laterality | 1 | 1996 | 2290 | 0.010 |
Why?
|
| Brain Diseases | 1 | 1996 | 1563 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 1996 | 39050 | 0.000 |
Why?
|